We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
(+220%)
Cap. Flow
+$6.91B
Cap. Flow
% of AUM
99.25%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.43B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.24B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$202M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$152M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$91.2M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$62.6M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$58.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$46.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.48% |
| 2 | Financials | 8.05% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Healthcare | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LKFT
2276
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.69B
| $19.3K | ﹤0.01% |
557
+124
| +29% | +$3.97K |
|
2277
Fresenius Medical Care
FMS
$12.8B
| $19.2K | ﹤0.01% |
+728
| New | +$18.7K |
|
2278
Fidelity MSCI Energy Index ETF
FENY
$1.96B
| $19.2K | ﹤0.01% |
775
| – | – |
|
2279
CoreCivic
CXW
$3.26B
| $19.1K | ﹤0.01% |
938
+775
| +475% | +$16.1K |
|
2280
Celcuity
CELC
$4.53B
| $19K | ﹤0.01% |
+384
| New | +$15.4K |
|
2281
Koppers
KOP
$1.01B
| $19K | ﹤0.01% |
677
+623
| +1,154% | +$19.2K |
|
2282
Community Health Systems
CYH
$412M
| $18.9K | ﹤0.01% |
+5,900
| New | +$17.7K |
|
2283
Vanguard Russell 3000 ETF
VTHR
$4.81B
| $18.9K | ﹤0.01% |
64
+14
| +28% | +$3.96K |
|
2284
Worthington Steel
WS
$1.92B
| $18.9K | ﹤0.01% |
622
+588
| +1,729% | +$18.8K |
|
2285
Arcus Biosciences
RCUS
$3.5B
| $18.9K | ﹤0.01% |
+1,386
| New | +$14.4K |
|
2286
TriSalus Life Sciences
TLSI
$287M
| $18.8K | ﹤0.01% |
4,048
+40
| +1% | +$187 |
|
2287
Bioventus
BVS
$944M
| $18.8K | ﹤0.01% |
+2,810
| New | +$19.5K |
|
|
ONIT
2288
Onity Group
ONIT
$290M
| $18.8K | ﹤0.01% |
+470
| New | +$18.9K |
|
2289
SM Energy
SM
$6.85B
| $18.8K | ﹤0.01% |
752
+417
| +124% | +$11.2K |
|
2290
ASE Group
ASX
$82.2B
| $18.8K | ﹤0.01% |
1,691
-2,946
| -64% | -$30.8K |
|
2291
Enviri
NVRI
$649M
| $18.8K | ﹤0.01% |
1,478
+762
| +106% | +$7.88K |
|
2292
CVR Partners
UAN
$1.34B
| $18.7K | ﹤0.01% |
208
| – | – |
|
2293
Energy Recovery
ERII
$439M
| $18.7K | ﹤0.01% |
+1,215
| New | +$17.1K |
|
2294
The RMR Group
RMR
$320M
| $18.7K | ﹤0.01% |
1,188
+1,091
| +1,125% | +$18.2K |
|
2295
Caleres
CAL
$490M
| $18.6K | ﹤0.01% |
1,426
+1,287
| +926% | +$18.6K |
|
|
OPTU
2296
Optimum Communications Inc
OPTU
$315M
| $18.5K | ﹤0.01% |
+7,673
| New | +$18.8K |
|
2297
Acadia Realty Trust
AKR
$2.84B
| $18.5K | ﹤0.01% |
917
+875
| +2,083% | +$16.9K |
|
|
JBS
2298
JBS N.V.
JBS
$44.9B
| $18.5K | ﹤0.01% |
1,236
+618
| +100% | +$9.01K |
|
|
PGRE
2299
DELISTED
Paramount Group
PGRE
| $18.4K | ﹤0.01% |
2,820
+2,030
| +257% | +$13.5K |
|
2300
Patria Investments
PAX
$1.82B
| $18.4K | ﹤0.01% |
1,262
+1,231
| +3,971% | +$17.2K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.
- Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
- Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
- Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
- Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
- Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
- Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
- Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.
Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.